Finally, the expression of β-catenin and some of the CSC markers analyzed in our study, such as ALDH1A1, Sox-2 or Oct-4, correlates with tumor grade, recurrence, metastasis or worse survival in patients with bladder cancer [8,39,40,41,42]. This evidence concerns the gene SOX2 and urinary bladder carcinoma.